Henry Schein (HSIC) vs Molina Healthcare (MOH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Henry Schein (HSIC) has outperformed Molina Healthcare (MOH) over the past year, gaining 28.9% versus a loss of 4.2%. Over five years, HSIC leads with a +8.0% price change compared with -30.4% for MOH. Molina Healthcare is the larger company by market cap ($10.17 billion vs $9.32 billion), about 1.1 times the size.
On valuation, Henry Schein trades at a lower forward P/E (14.0x vs 20.0x for Molina Healthcare). Henry Schein converts more of its revenue into profit, with a net margin of 3.0% versus 1.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSIC | MOH |
|---|---|---|
| Share price | $83.66 | $194.82 |
| Market cap | $9.32B | $10.17B |
| 1-day change | -1.39% | -0.18% |
| YTD return | +10.69% | +12.26% |
| 1-year return | +28.95% | -4.15% |
| 5-year return | +8.03% | -30.44% |
| P/E ratio (TTM) | 24.39 | — |
| Forward P/E | 13.98 | 19.99 |
| EPS (TTM) | $3.43 | $0.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $13.18B | $45.43B |
| Revenue growth (YoY) | +4.03% | +11.75% |
| Net income (latest FY) | $398.00M | $472.00M |
| Gross margin | 31.14% | 13.07% |
| Operating margin | 4.95% | 1.72% |
| Net margin | 3.02% | 1.04% |
| 52-week high | $92.18 | $244.89 |
| 52-week low | $61.95 | $121.06 |
| Distance from 52-week high | -9.24% | -20.45% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +16.27% | +7.34% |
| Average volume | 1.20M | 915.40K |
| Shares outstanding | 111.45M | 52.20M |
| Employees | 25,000 | 19,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HSIC has outperformed MOH by 33.1 percentage points over the past year.
- Molina Healthcare grew revenue faster in its latest fiscal year (+11.75% vs +4.03%).
About Henry Schein
HSIC stock →Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide.
Health Care · Medical Specialities · 25,000 employees
About Molina Healthcare
MOH stock →Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States.
Health Care · Medical Specialities · 19,000 employees
HSIC vs MOH FAQ
Which is bigger, Henry Schein or Molina Healthcare?
Molina Healthcare (MOH) is larger, with a market capitalization of $10.17B compared with $9.32B for Henry Schein (HSIC).
Which stock has performed better over the past year, HSIC or MOH?
HSIC returned +28.95% over the past 12 months, compared with -4.15% for MOH (price return, excluding dividends). Past performance does not predict future results.
Are Henry Schein and Molina Healthcare in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.